Article

Bausch & Lomb earns NTIOL status for two lens products

Bausch & Lomb has earned NTIOL status for its SofPort Advanced Optics and SofPort Advanced Optics with Violet Shield lenses.

Key Points

Rochester, NY-The Centers for Medicare and Medicaid Services has granted new technology IOL (NTIOL) designation to two lenses (SofPort Advanced Optics and SofPort Advanced Optics with Violet Shield, Bausch & Lomb) for their spherical aberration-reducing design.

Based on this new designation, which was effective March 6, Medicare will increase by $50 its reimbursement to ambulatory surgery centers when cataract procedures are performed with either of these lenses.

The NTIOL designation and adjusted payment will remain in effect until Feb. 26, 2011.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.